Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Makena: New Randomized Trial May Only Happen If Drug Stays On The US Market
Oct 19 2022
•
By
Sue Sutter
Covis declined to offer a clear view on whether it would do another trial in Makena were removed from the market. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Review Pathways
More from Pathways & Standards